Latest It Compliance News

Magnum Mining & Exploration has completed its acquisition of Palmares Estudos Geologicos LTDA, securing a significant rare earths landholding in Brazil after an extended due diligence process.

Epsilon Healthcare reports ongoing operational challenges post-voluntary administration while unveiling a new pharmacy subsidiary aimed at diversifying revenue streams and rebuilding market confidence.

Spenda Limited has responded to an ASX price query following a notable rise in its share price and trading volume, denying any undisclosed material information while confirming ongoing confidential negotiations for virtual card and funding services.

Finexia Financial Group announces the resignation of Interim CEO Marc Duncan as the Board intensifies its review of credit operations and pursues ASX securities reinstatement.

Papyrus Australia has issued a revised Appendix 4C for the March 2025 quarter, correcting the treatment of $527k in R&D expenditure previously reported as cash payments. This adjustment also impacts prior monthly and quarterly cash flow reports dating back to November 2024.

Kinatico (ASX:KYP) has upgraded its SaaS revenue forecast for the second half of FY25 to $8.3 million, driven by strong demand for its compliance and credential validation software. The company’s recent sales hires and April launch of Kinatico Compliance underpin this optimistic outlook.

Pact Group Holdings has received conditional approval from the ASX for its voluntary delisting, pending shareholder endorsement at an upcoming extraordinary general meeting scheduled for 12 June 2025.

Citigold Corporation Limited has had its trading suspension lifted immediately following the submission of its reissued half year financial report and responses to ASX compliance queries.

Citigold Corporation Limited has faced intense ASX scrutiny following an adverse auditor opinion on its half-year financials, centering on a $20 million impairment of exploration assets. The company defends its valuation approach despite funding uncertainties and regulatory questions.

Neurotech International has reported excellent safety and tolerability for its lead drug NTI164 in 28-day GLP toxicology studies, paving the way for regulatory submissions and longer-term clinical development.

Northern Star Resources has completed its acquisition of De Grey Mining through a scheme of arrangement, issuing new shares to De Grey shareholders and initiating De Grey’s imminent ASX delisting.

Northern Star Resources has completed its acquisition of De Grey Mining, issuing new shares and preparing to delist De Grey from the ASX, marking a strategic expansion into Western Australia's Hemi gold project.